BCPC - Balchem - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0576652004
Nutrition, Food, Pharmaceuticals, Animal Feed, Sterilization, Crop Protection
Balchem Corporation is a leading global developer, manufacturer, and marketer of specialty performance ingredients and products, catering to a diverse range of industries including nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets.
The company operates through three distinct segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition and Health segment is a key player in the food and beverage industry, supplying a wide range of ingredients such as spray-dried and emulsified powders, extrusion and agglomeration, blended lipid systems, and liquid flavor delivery systems. Additionally, this segment offers specialty vitamin K2, microencapsulation solutions, and human-grade choline nutrients and mineral amino acid chelated products for nutrition and health applications.
The Animal Nutrition and Health segment focuses on enhancing health and milk production in ruminant animals through microencapsulated products, as well as delivering nutrient supplements. This segment also utilizes chelation technology to offer enhanced nutrient absorption for various species of production and companion animals. Furthermore, it provides methylsulfonylmethane and choline chloride, a nutrient essential for monogastric animal health.
The Specialty Products segment plays a critical role in the healthcare industry, distributing ethylene oxide and ammonia for sterilization purposes, as well as single-use canisters for sterilizing reusable devices. This segment also markets and sells propylene oxide, a fumigant used to control insects and microbiological spoilage in various food products, including nuts, spices, and cocoa powder. Moreover, it offers chelated minerals for high-value crops, supporting the agricultural industry.
Balchem Corporation's products are sold through a combination of its sales force, independent distributors, and sales agents, ensuring a strong global presence. With a rich history dating back to 1967, the company is headquartered in Montvale, New Jersey, and continues to drive innovation and growth in the specialty ingredients and products market.
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
BCPC Stock Overview
Market Cap in USD | 5,784m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC SubIndustry | Specialty Chemicals |
TER | 0.00% |
IPO / Inception | 1986-06-03 |
BCPC Stock Ratings
Growth 5y | 61.7 |
Fundamental | 70.4 |
Dividend | 39.2 |
Rel. Performance vs Sector | 0.92 |
Analysts | 4.00/5 |
Fair Price Momentum | 180.26 USD |
Fair Price DCF | 121.94 USD |
BCPC Dividends
Dividend Yield 12m | 0.69% |
Yield on Cost 5y | 1.24% |
Dividends CAGR 5y | 17.98% |
Payout Consistency | 88.8% |
BCPC Growth Ratios
Growth 12m | 37.63% |
Growth Correlation 12m | 89% |
Growth Correlation 3m | 17% |
CAGR 5y | 12.38% |
CAGR/Mean DD 5y | 0.89 |
Sharpe Ratio 12m | 1.36 |
Alpha vs SP500 12m | 14.83 |
Beta vs SP500 5y weekly | 0.59 |
ValueRay RSI | 37.26 |
Volatility GJR Garch 1y | 24.22% |
Price / SMA 50 | 0.52% |
Price / SMA 200 | 10.09% |
Current Volume | 62.6k |
Average Volume 20d | 118.6k |
External Links for BCPC Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of October 06, 2024, the stock is trading at USD 172.25 with a total of 62,558 shares traded.
Over the past week, the price has changed by -1.64%, over one month by -0.17%, over three months by +7.31% and over the past year by +38.14%.
According to ValueRays Forecast Model, BCPC Balchem will be worth about 197.3 in October 2025. The stock is currently trading at 172.25. This means that the stock has a potential upside of +14.53%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 188.7 | 9.53 |
Analysts Target Price | 157 | -8.85 |
ValueRay Target Price | 197.3 | 14.5 |